Cytokinetics, Incorporated (NASDAQ:CYTK) Shares Acquired by Vanguard Group Inc.
Vanguard Group Inc. raised its holdings in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 1.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,915,821 shares of the biopharmaceutical company’s stock after purchasing an additional 154,216 shares during the […]
Vanguard Group Inc. raised its holdings in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 1.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,915,821 shares of the biopharmaceutical company’s stock after purchasing an additional 154,216 shares during the […]
